Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species

Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts

1998 • 576 citations

Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors

1997 • 321 citations

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

1997 • 312 citations

In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp

2002 • 284 citations

International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents

1999 • 270 citations

In Vitro Activity of Two Echinocandin Derivatives, LY303366 and MK-0991 (L-743,792), Against Clinical Isolates of Aspergillus, Fusarium, Rhizopus, and Other Filamentous Fungi

1998 • 240 citations

Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents

2000 • 220 citations

In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus and Fusarium Isolates

2001 • 207 citations

In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds

1997 • 166 citations

Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies

1996 • 139 citations

Comparative Evaluation of NCCLS M27-A and EUCAST Broth Microdilution Procedures for Antifungal Susceptibility Testing of Candida Species

2002 • 139 citations

In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species

1997 • 117 citations

Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.

1998 • 109 citations

Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans

1997 • 102 citations

Evaluation of Broth Microdilution Testing Parameters and Agar Diffusion Etest Procedure for Testing Susceptibilities of Aspergillus spp. to Caspofungin Acetate (MK-0991)

2003 • 94 citations

Caspofungin

2001 • 82 citations

Evaluation of Etest Method for Determining Caspofungin (MK-0991) Susceptibilities of 726 Clinical Isolates of Candida Species

2001 • 63 citations

Influences of Methodological Variables on Susceptibility Testing of Caspofungin against Candida Species and Aspergillus fumigatus

2003 • 62 citations

In vitrogrowth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistantCandidaisolates: influence of assay conditions

1997 • 53 citations

Disk Diffusion Method for Determining Susceptibilities of Candida spp. to MK-0991

1999 • 43 citations

Susceptibility testing of pathogenic fungi with itraconazole: a process analysis of test variables

2001 • 39 citations

Evaluation of the in vitro activity of caspofungin against bloodstream isolates of Candida species from cancer patients: comparison of Etest and NCCLS reference methods

2002 • 27 citations

Proficiency Testing Program for Clinical Laboratories Performing Antifungal Susceptibility Testing of Pathogenic Yeast Species

2003 • 13 citations